FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Peptide patents



      
           
This page is updated frequently with new Peptide-related patent applications. Subscribe to the Peptide RSS feed to automatically get the update: related Peptide RSS feeds. RSS updates for this page: Peptide RSS RSS


Date/App# patent app List of recent Peptide-related patents
04/30/15
20150121573
 Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same patent thumbnailnew patent Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same
Nucleic acid constructs are provided. These constructs comprise any of the, nucleic acid sequences at least 85% identical to nucleotide sequences selected from the group consisting of seq id nos: 68, 1, 4, 5, 8, 9, 11, 13, 16, 19, 20, 23, 24, 27, 30, 32, 37, 42, 49, 50, 51, 53, 54, 55, 56, 57, 58, 64, 69, 70, 73, 77, 78, 79, 80, 84, 86, 87, 93, 94, 98, 101, 102, 103, 104, 105, 106, 107, 108 and 109 and a promoter sequence capable of directing transcription of said nucleic acid sequence in a host cell.
Evogene Ltd.
04/30/15
20150121569
 Micropeptides and use thereof for modulating gene expression patent thumbnailnew patent Micropeptides and use thereof for modulating gene expression
Process for detecting and identifying micropeptides (mipeps) encoded by a nucleotide sequence contained in the sequence of the primary transcript of a microrna and use thereof for modulating gene expression.. .
Unitersite Paul Sabatier Toulouse Iii
04/30/15
20150119552
 Aromatic-cationic peptides and uses of same patent thumbnailnew patent Aromatic-cationic peptides and uses of same
Disclosed herein are compositions and methods related to aromatic-cationic peptides. In particular, the compositions and methods relate to aromatic-cationic peptides in conjunction with cytochrome c.
Stealth Peptides International, Inc.
04/30/15
20150119551
 Stabilized p53 peptides and uses thereof patent thumbnailnew patent Stabilized p53 peptides and uses thereof
Cross-linked peptides related to human p53 and bind to hmd2 or a family member of hdm2 useful for promoting apoptosis, e.g., in the treatment of and identifying therapeutic agents that binding to hmd2 or a family member of hdm2.. .
Dana-farber Cancer Institute, Inc.
04/30/15
20150119403
 Mutant ros expression in human cancer patent thumbnailnew patent Mutant ros expression in human cancer
The invention provides the identification of the presence of mutant ros protein in human cancer. In some embodiments, the mutant ros are fig-ros fusion proteins comprising part of the fig protein fused to the kinase domain of the ros kinase.
Cell Signaling Technology, Inc.
04/30/15
20150119345
 Bile acid recycling inhibitors for treatment of gastrointestinal infections patent thumbnailnew patent Bile acid recycling inhibitors for treatment of gastrointestinal infections
Provided herein are methods for treating or preventing gastrointestinal and/or liver infections utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents and/or fxr agonists. Also provided herein are methods for increasing the levels of an enteroendocrine peptide or hormone in an individual suffering from a gastrointestinal infection or liver infection utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents and/or fxr agonists..
Lumena Pharmaceuticals, Inc.
04/30/15
20150119343
 Production of tsg-6 protein patent thumbnailnew patent Production of tsg-6 protein
A method of producing a protein or polypeptide, such as, for example, tsg-6 protein, or a biologically active fragment, derivative or analogue thereof, by introducing into mammalian cells a polynucleotide encoding the biologically active protein or polypeptide or biologically active fragment, derivative, or analogue thereof. The cells then are suspended in a protein-free medium that includes at least one agent that suppresses production of hyaluronic acid, hyaluronan, or a salt thereof by the cells.
The Texas A & M University System
04/30/15
20150119341
 Melanocortin-1 receptor-specific linear peptides patent thumbnailnew patent Melanocortin-1 receptor-specific linear peptides
Where r1, r2, r3, r4, r5, r6, r7, r8, r9 and r10 are as defined in the specification, compositions and formulations including peptides of the foregoing formula or salts thereof, and pharmaceutical compositions for preventing, ameliorating or treating melanocortin-1 receptor-mediated or responsive diseases, indications, conditions and syndromes.. .
04/30/15
20150119340
 Fusion peptide and use thereof for cell membrane penetrating patent thumbnailnew patent Fusion peptide and use thereof for cell membrane penetrating
A fusion peptide including a hydrophobic peptide and a basic peptide, a pharmaceutical composition including the fusion peptide, a cell membrane penetrating conjugate including the fusion peptide and a substance of interest, and a method for intracellular delivery of a substance of interest using the fusion peptide.. .
Samsung Electronics Co., Ltd.
04/30/15
20150119338
 Uses of modified human tumor necrosis factor receptor-1 polypeptide patent thumbnailnew patent Uses of modified human tumor necrosis factor receptor-1 polypeptide
The present invention relates to new uses of modified human tumor necrosis factor receptor-1 (tnfri) polypeptide, and more particularly, to uses thereof for prevention and treatment of dry eye syndrome. The modified tnfri or modified tnfri fragment of the present invention has excellent tnfα neutralizing activity, and inhibits tnfα activity on the ocular surface of the patient to suppress inflammation induction effects related to dry eye.
Hanall Biopharma Co., Ltd.
04/30/15
20150119336
new patent

Polymers containing multivalent amyloid-beta-binding d-peptides and their use


The invention relates to novel multivalent polymeric amyloid-beta-binding substances composed of several interconnected substances which per se already have amyloid-beta-binding properties, and to the use of these substances, referred to hereinbelow as “polymers”, in particular in medicine.. .
Forschungszentrum Juelich Gmbh
04/30/15
20150119334
new patent

Functionalized titanium binding peptides and implants coated with same


Use of the peptides and titanium devices comprising same are also disclosed.. .
04/30/15
20150119333
new patent

Methods of inhibiting adverse cardiac events and treating atherosclerosis and coronary artery disease using galectin-3 binding protein (gal-3bp, btbd17b, mac-2 binding protein)


The invention provides galectin-3 binding protein (gal-3bp, btbd17b) polypeptide sequences and compositions that include gal-3bp polypeptide sequences, and methods of using gal-3bp polypeptide sequences, including modified forms and wild type (native) forms of gal-3bp polypeptide, such as in treatment, diagnostic, detection and prognostic methods.. .
La Jolla Institute For Allergy And Immunology
04/30/15
20150119332
new patent

Isoform-selective inhibitors and activators of pde3 cyclic nucleotide phosphodiesterases


The present invention concerns methods and compositions related to type 3 phosphodiesterases (pde3). Certain embodiments concern isolated peptides corresponding to various pde3a isoforms and/or site-specific mutants of pde3a isoforms, along with expression vectors encoding such isoforms or mutants.
The United States Government, As Represented By The Department Of Veterans Affairs
04/30/15
20150119328
new patent

Treatments for gastrointestinal disorders


Described herein are peptides, compositions, and related methods for treating upper gastrointestinal disorders and conditions (e.g., dyspepsia, gastroparesis, post-operative gastric ileus, a functional esophageal disorder, a functional gastroduodenal disorder, gastroesophageal reflux disease (gerd), or a duodenal or stomach ulcer) as well as other conditions and disorders that are described herein.. .
Ironwood Pharmaceuticals, Inc.
04/30/15
20150119318
new patent

Peptide compositions and methods for inhibiting herpesvirus infection


The present invention provides an isolated peptide having an amino acid residue sequence that comprises at least one human cytomegalovirus glycoprotein b (hcmv-gb) sequence segment, each hcmv-gb sequence segment consisting of at least 8 and not more than 60 consecutive amino acid residues from residues 146 to 315, residues 476 to 494 of seq id no: 1, or from a sequence variant of residues 146 to 315 or 476 to 494 of seq id no: 1 that has at least 70% sequence identity thereto. The peptides of the invention are useful for treating, preventing, or inhibiting a herpesvirus (e.g., herpes simplex virus-1, human cytomegalovirus, and the like) infection in a subject..
The Administrators Of The Tulane Educational Fund
04/30/15
20150119294
new patent

Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants


The invention provides compositions and methods for generating libraries of dna sequences encoding homologous polypeptides, and uses of the libraries to identify naturally diversified polypeptide variants. The invention also provides compositions and methods for generating collections of synthetic antibody fragments in which one or several complementary determining regions (cdr) are replaced by a collection of the corresponding cdr captured from a natural source.
Novimmune S.a.
04/30/15
20150119293
new patent

Synthetic ligation reassembly in directed evolution


A directed evolution process for rapid and facilitated production from a progenitor polynucleotide template, of a library of mutagenized progeny polynucleotides wherein each of the 20 naturally encoded amino acids is encoded at each original codon position. This method, termed site-saturation mutagenesis, or simply saturation mutagenesis, is preferably based on the use of the degenerate n,n,g/t sequence.
Bp Corporation North America Inc.
04/30/15
20150119276
new patent

Immunoreactive ehrlichia p120/p140 epitopes and uses thereof


Provided herein are immunoreactive peptides which can selectively bind ehrlichia-specific anti-p120 or anti-p140 antibodies. Methods and kits utilizing the immunoreactive peptides are also provided.
Research Development Foundation
04/30/15
20150119251
new patent

Agricultural plant-protecting agents containing dipeptide derivative as active ingredient


Provided is an agricultural plant-protecting agent including a dipeptide derivative or an agro-pharmaceutically acceptable salt thereof as an active ingredient, which has a plant disease-preventing effect, a plant growth-promoting effect, and a plant immunity-activating effect.. .
Napro Biotec Inc.
04/30/15
20150118734
new patent

Inducible gene expression composition for using eukaryotic pol-2 promoter-driven transcription in prokaryotes and the applications thereof


Eukaryotic protein-coding messenger rnas and non-coding micrornas are naturally transcribed by type ii rna polymerases (pol-2) but not prokaryotic rna polymerases. As a result, current eukaryotic rna and protein production is performed either using eukaryotic pol-2 promoters in hybridomas or mammalian cells or using prokaryotic promoters in bacterial cells.
Mello Biotechnology, Inc.
04/30/15
20150118731
new patent

Antimicrobial agents


The application relates to antimicrobial agents against gram-negative bacteria, in particular to fusion proteins composed of an enzyme having the activity of degrading the cell wall of gram-negative bacteria and a peptide stretch fused to the enzyme at the n- or c-terminus, as well as pharmaceutical compositions comprising the same. Moreover, it relates to nucleic acid molecules encoding such a fusion protein, vectors comprising said nucleic acid molecules and host cells comprising either said nucleic acid molecules or said vectors.
Katholieke Universiteit Leuven, K.u. Leuven R&d
04/30/15
20150118726
new patent

Processes using antibiotic alternatives in bioethanol production


Methods for controlling the growth of bacteria in ethanol fermentation systems with antibiotic alternatives, which can be nonoxidizing biocides, stabilized oxidizers, or any combinations thereof, are described. As an option, a process or composition of the present invention can include one or more polycyclic antibacterial peptides.
Buckman Laboratories International, Inc.
04/30/15
20150118719
new patent

Biocatalysts and methods for hydroxylation of chemical compounds


The present disclosure provides engineered proline hydroxylase polypeptides for the production of hydroxylated compounds, polynucleotides encoding the engineered proline hydroxylases, host cells capable of expressing the engineered proline hydroxylases, and methods of using the engineered proline hydroxylases to prepare compounds useful in the production of active pharmaceutical agents. The present disclosure provides engineered proline hydroxylase biocatalysts, polynucleotides encoding the biocatalysts.
Codexis, Inc.
04/30/15
20150118709
new patent

Corn active peptide additive for cell culture medium


The present invention provides a corn active peptide additive for cell culture medium, wherein in the corn active peptide additive, oligopeptides with molecular weight of lower than 1000 dalton account for equal to or more than 90 wt % of total proteins, and the oligopeptides at least comprise one or more of ap, sap, pal, vnap, pssq, and tqpgpq. The corn active peptide additive of the present invention can be compounded with various basic culture mediums for serum-free culture of various animal cells, which not only substantially lowers the cost for cell culturing and reduces pollution and other problems caused by an animal derived component, but also can promote cell proliferation, improve cell viability and enhance expression of cell products..
China National Research Institute Of Food And Fermentation Industries
04/30/15
20150118701
new patent

Enzyme assay with duplicate fluorophores


Compositions and methods are disclosed that provide a rapid, sensitive, and accurate cell-based assay for enzyme activity, particularly for enzyme activities associated with botulinum toxins. A cell is provided that expresses a construct that includes an anchor region, a cleavage site, and a reporting region having two or more identical reporter peptides.
Biomadison, Inc.
04/30/15
20150118700
new patent

Modified amadoriase reacting with fructosyl hexapeptide


This invention provides an amadoriase having high reactivity with α-fructosyl hexapeptide (αf6p) derived from the β-chain amino terminus of glycated hemoglobin (hbalc), which enables satisfactory quantification of αf6p cleaved from hbalc. A novel amadoriase is derived from the amadoriase of the genus coniochaeta by substitution of one or more amino acids at positions selected from the group consisting of positions 62, 63, 102, 106, 110, 113, 355, and 419.
Kikkoman Corporation
04/30/15
20150118698
new patent

Biochemical markers for cvd risk assessment


A method of bioassay for the quantification of peptide fragments comprising a neo-epitope formed by cleavage ofmimecan, a protein of an atherosclerotic plaque, by a proteinase, said comprises contacting a sample such as urine or serum with an antibody reactive with the neo-epitope and determining the level of binding of said immunological binding partner to peptide fragments in said sample. The assay is predictive of risk of cardiovascular disease events..
Nordic Biociences A/s
04/30/15
20150118385
new patent

Method for increasing photosynthetic carbon fixation in rice


The invention relates to a method for stimulating the growth of the plants and/or improving the biomass production and/or increasing the carbon fixation by the plant comprising introducing into a rice plant cell, rice plant tissue or rice plant one or more nucleic acids, wherein the introduction of the nucleic acid(s) results inside the chloroplast of a de novo expression of one or more polypeptides having the enzymatic activity of a glycolate dehydrogenase.. .
Bayer Bioscience N.v.
04/30/15
20150118356
new patent

Chymosine enzyme variants


Said positions being defined with reference to seq id no: 2 and wherein the variant has one or more altered properties as compared with a reference polypeptide having chymosin activity. Such a variant polypeptide may be used in the preparation of a cheese..
04/30/15
20150118336
new patent

Engineered rice having alcoholism relief and liver protection function, and preparation method thereof


The present invention relates to a functional engineered rice having alcoholism relief and liver protection functions for those drinking alcohol over an extended period of time or drinking alcohol excessively, and preparation method thereof. The engineered rice comprises six starting materials: coarse rice powder, isolated soy protein, kudzu root extract, corn oligopeptide, purple sweet potato powder, and hawthorn extract, and is prepared by: premixing the starting materials; employing a double screw extruder to conduct texturized processing and forming under high temperature and high pressure; and then drying, dedusting and packaging.
Perfect (china) Co., Ltd.
04/30/15
20150118319
new patent

Proteolysis-resistant capsid of chimeric hepatitis e virus as an oral delivery vector


This invention provides a peptide/nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.. .
The Regents Of The University Of California
04/30/15
20150118315
new patent

Aromatic-cationic peptides and uses of same


A finished pharmaceutical product adapted for oral delivery of an aromatic-cationic peptide, wherein the product comprises a therapeutically effective amount of the peptide; at least one pharmaceutically acceptable ph-lowering agent; and at least one absorption enhancer effective to promote bioavailability of the active agent. The product is adapted for use in a method for enhancing the bioavailability of a therapeutic aromatic-cationic peptide delivered orally..
Stealth Peptides International, Inc.
04/30/15
20150118292
new patent

Compositions and methods for treatment of hair loss


The present invention is directed to compositions and methods suitable for the treatment of alopecia by topical application include minoxidil sulfate, finasteride, and 17α-estradiol. The combination is characterized by low alcohol content to minimize skin irritation and may be enhanced with the addition of vitamins, minerals, and peptides.
04/30/15
20150118290
new patent

Method for reducing established metastatic tumor by pharmaceutical composition containing polypeptide


A method for reducing an established metastatic tumor, comprising administering an effective amount of a pharmaceutical composition to a subject in need, wherein the pharmaceutical composition comprises a polypeptide of a fibronectin-binding domain of dipeptidyl peptidase iv having a maltose-binding protein (mbp) fused at an n-terminal thereof, a cross-linking molecule, an active agent, and a pharmaceutically acceptable carrier.. .
National Cheng Kung University
04/30/15
20150118289
new patent

Nanoparticle, preparating the same, and use of the nanoparticle


A nanoparticle including a hydrophobic active ingredient and a polypeptide, as well as a liposome including the nanoparticle and methods of making and using the nanoparticle.. .
Samsung Electronics Co., Ltd.
04/30/15
20150118287
new patent

Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions


In alternative embodiments, the invention provides methods for treating, ameliorating or protecting (preventing) an individual or a patient against a disease, an infection or a condition responsive to an increased paracrine polypeptide level in vivo comprising: providing a paracrine polypeptide-encoding nucleic acid or gene operatively linked to a transcriptional regulatory sequence; or an expression vehicle, a vector, a recombinant virus, or equivalent, having contained therein a paracrine-encoding nucleic acid or gene, and the expression vehicle, vector, recombinant virus, or equivalent can express the paracrine-encoding nucleic acid or gene in a cell or in vivo; and administering or delivering the paracrine polypeptide-encoding nucleic acid or gene operatively linked to a transcriptional regulatory sequence, or the expression vehicle, vector, recombinant virus, or equivalent, to an individual or a patient in need thereof, thereby treating, ameliorating or protecting (preventing) the individual or patient against the disease, infection or condition responsive to an increased paracrine polypeptide level.. .
The Regents Of The University Of California
04/30/15
20150118286
new patent

Peptide tyrosinase inhibitors and uses thereof


Disclosed are peptides that inhibit the enzymatic activity of tyrosinase, as well as formulations and methods for their use in the reduction of skin pigmentation, and methods of administering the inhibitory peptides in a topical formulation. Preferred octapeptide sequences are internally rich in tryptophan and/or tyrosine or arginine.
Elixir Institute Of Regenerative Medicine
04/30/15
20150118264
new patent

Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen


The present invention is directed to a pharmaceutical composition including (e.g. For use as an adjuvant) a polymeric carrier cargo complex, comprising as a carrier a polymeric carrier formed by disulfide-crosslinked cationic components; and as a cargo at least one nucleic acid molecule, and at least one antigen that is selected from an antigen from a pathogen associated with infectious disease; an antigen associated with allergy or allergic disease; an antigen associated with autoimmune disease; or an antigen associated with a cancer or tumour disease, or in each case a fragment, variant and/or derivative of said antigen.
Curevac Gmbh
04/30/15
20150118262
new patent

Haemophilus influenzae type iv pili


The invention described herein relates to a haemophilus influenzae (h. Influenzae) regulon encoding type iv pili.
Nationwide Children's Hospital, Inc.
04/30/15
20150118256
new patent

Ige ch3 peptide vaccine


The present invention relates to the provision of novel immunogens comprising an antigenic ige peptide preferably linked to an immunogenic carrier, compositions comprising the immunogens, and methods for the prevention, treatment or alleviation of ige-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine..
Pfizer Vaccines Llc
04/30/15
20150118250
new patent

Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species


The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein said at least two recombinant nucleotide sequences are inserted into distinct non-coding region of the viral genome chosen among the region located between ul44 and ul45, the region located between ul45 and ul46, the region located between us10 and sorf3, the region located between sorf3 and us2.. .
Ceva Sante Animale
04/30/15
20150118241
new patent

Lingo-2 antagonists for treatment of conditions involving motor neurons


The invention provides methods of treating diseases, disorders or injuries involving motor neuron survival and axonal growth, including amylotrophic lateral sclerosis, by the administration of a lingo-2 antagonist. An exemplary method for promoting survival of a motor neuron, comprising contacting said motor neuron with an effective amount of a composition comprising a lingo-2 antagonist selected from the group consisting of: (i) a soluble lingo-2 polypeptide; (ii) a lingo-2 antibody or antigen-binding fragment thereof; (iii) a lingo-2 antagonist polynucleotide; (iv) a lingo-2 aptamer; and (v) a combination of two or more of said lingo-2 antagonists..
Biogen Idec Ma Inc.
04/30/15
20150118233
new patent

Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections


The invention also relates to the uses of such amino acid sequences, polypeptides, compounds or constructs for prophylactic and/or therapeutic purposes.. .
04/30/15
20150118226
new patent

Antibodies directed against nerve growth factor (ngf)


The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that binds to nerve growth factor (ngf). The invention provides an ngf-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide.
Anaptysbio, Inc.
04/30/15
20150118213
new patent

Compounds and methods for stabilizing thrombin activity


The present invention is directed to compounds useful in stabilizing thrombin activity, thrombin compositions comprising the compounds, methods of using the compounds and methods of identifying compounds capable of stabilizing thrombin activity. The compounds are preferably isolated peptides comprising or interacting with the gamma loop of thrombin..
Omrix Biopharmaceuticals Ltd.
04/30/15
20150118189
new patent

Polypeptide mixes with antibacterial activity


The invention relates to the field of microbiology, specifically to a combination of a source of a first enzymatic active domain and a source of a second enzymatic active domain and to a composition comprising said combination. The invention further relates to a composition comprising said combination for use as a medicament, to the use of said composition as an antimicrobial agent and to a method for controlling microbial contamination in a food- or feed product, on and/or in food- or feed processing equipment, on and/or in food- or feed containers..
Micreos Human Health B.v.
04/30/15
20150118187
new patent

Micro-organs providing sustained delivery of a therapeutic polypeptide and methods of use thereof


The present invention is directed to long-lasting therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a nucleic acid sequence operably linked to one or more regulatory sequences. The present invention is further directed to methods providing sustained expression of therapeutic polypeptides and prolonged therapeutic effects, such as erythropoietin and interferon..
Medgenics Medical Israel Ltd.
04/30/15
20150118185
new patent

Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making and using same


Compositions containing conjugates of heparosan polymer with at least one drug are disclosed, along with methods of production and use thereof.. .
The Board Of Regents Of The University Of Oklahoma
04/30/15
20150118183
new patent

Negatively charged nucleic acid comprising complexes for immunostimulation


The present invention is directed to a pharmaceutical composition including (e.g., for use as an adjuvant) a (negatively charged) nucleic acid comprising complex comprising as a carrier cationic or polycationic compounds (e.g. Peptides, proteins or polymers) and as a cargo at least one nucleic acid (molecule) and at least one antigen that is selected from an antigen from a pathogen associated with infectious disease; an antigen associated with allergy or allergic disease; an antigen associated with autoimmune disease; or an antigen associated with a cancer or tumour disease, or in each case a fragment, variant and/or derivative of said antigen.
Curevac Gmbh
04/30/15
20150118181
new patent

Concurrent chemotherapy and immunotherapy


The concurrent administration of chemotherapy and immunotherapy has been considered a contraindication because of the concern that the induced lymphopenia would ablate therapeutic efficacy of immunotherapy. Temozolomide has been shown to be an effective chemotherapeutic for patients with malignant gliomas and to deprive patients with glioblastoma (gbm) patients of this agent in order to treat with immunotherapy is controversial.
Duke University
04/30/15
20150118158
new patent

Method for detecting and purifying pancreatic beta cells


The invention is based, in part, on the discovery that a polypeptide, referred to herein as betacam, is selectively expressed on the surface of pancreatic islet cells. Thus, in one aspect, the invention is directed to compositions comprising betacam or that can be used to detect betacam.
The Regent Of The University Of Colorado, A Body Corporate


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Peptide for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Peptide with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         















0.476

3692

2 - 1 - 83